PET-CT Exam Volumes: Comparison of Canada With Other Countries

PET-CT Exam Volumes: Comparison of Canada With Other Countries Canadian Medical Imaging Inventory Service Report PET-CT Exam Volumes: Comparison of Canada With Other Countries Context The increase in the adoption and use of PET-CT is attributed to its precision and ability to help save health care costs, particularly in the field of oncology.1,2,3,4 This increase is evident in Canada, where a rise. [...] This may be an indicator that processes and resources may not be in place for clinicians to refer patients for PET-CT exams that could be of benefit to them.5 The identification of different aspects of PET-CT service provisions that influence exam volumes may help improve health care efficiencies and patient-related outcomes. [...] A 30% decrease in fluorodeoxyglucose PET activity in England was observed during April and May of 2020.6 Public health measures introduced in England to curb this wave of the pandemic may have impacted the number of individuals seeking health services that could increase their risk of contracting COVID-19, including diagnostic imaging.6 Table 1 provides more detailed information on the PET-CT exam. [...] The CADTH report Publicly Funded PET-CT Indications: Comparison of Canada With Other Countries provides details on the coverage for PET-CT indications in Australia, Scotland, the UK (England, Northern Ireland, and Wales), and Canada. [...] The Canadian Agency for Drugs and Technologies in Health (CADTH) does not guarantee the accuracy, completeness, or currency of the contents of this document.